Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 7 of 23
Nuclera
CIC Fund II
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2022
Hold
4yr
Owners
3
Owkin
Otium Venture
FranceSector
Biotech
InvestorFRST Capital
Entry
2013
Hold
13yr
Owners
3
Sibylla Biotech
Claris Biotech I
ItalySector
Biotech
InvestorClaris Ventures SGR
Entry
2019
Hold
7yr
Owners
3
smartbax
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2021
Hold
5yr
Owners
3
StimOxyGen
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2025
Hold
1yr
Owners
3
Telum Therapeutics
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2020
Hold
6yr
Owners
3
Therini Bio
Apollo Health Ventures Fund II
United StatesSector
Biotech
InvestorApollo Health Ventures
Entry
2020
Hold
6yr
Owners
3
TreeFrog Therapeutics
Galia Investissements IV
FranceSector
Biotech
InvestorGalia Gestion
Entry
2018
Hold
8yr
Owners
3
Trogenix
Old College Capital LP
UKSector
Biotech
InvestorOld College Capital
Entry
2023
Hold
3yr
Owners
3
Vivet Therapeutics
Columbus Innvierte Life Science Fund I
FranceSector
Biotech
InvestorColumbus Venture Partners
Entry
2016
Hold
10yr
Owners
3
ActiTrexx
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
Owners
2
Adrenomed
Fruehphasen- und Wachstumsfonds Brandenburg
GermanySector
Biotech
InvestorBrandenburg Kapital
Entry
2018
Hold
8yr
Owners
2
Aerska
BlueYard Capital Fund III
UKSector
Biotech
InvestorBlueYard Capital
Entry
2025
Hold
1yr
Owners
2
Akribion Therapeutics
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
Owners
2
ALKemist Bio
LIFTT
ItalySector
Biotech
InvestorLIFTT
Entry
2023
Hold
3yr
Owners
2
Alveus Therapeutics
Jeito II
FranceSector
Biotech
InvestorJeito Capital
Entry
2026
Hold
0yr
Owners
2
AMADIX
CRB Bio II
SpainSector
Biotech
InvestorCRB Health Tech
Entry
2011
Hold
15yr
Owners
2
Atelerix
Angel CoFund
UKSector
Biotech
InvestorACF Investors
Entry
2018
Hold
8yr
Owners
2
AviadoBio
Dementia Discovery Fund
UKSector
Biotech
InvestorSV Health Managers
Entry
2020
Hold
6yr
Owners
2
Basecamp Research
Singular Ventures II
FranceSector
Biotech
InvestorSingular Capital Partners
Entry
2023
Hold
3yr
Owners
2
BioLamina
Lauxera Growth I
SwedenSector
Biotech
InvestorLauxera Capital Partners
Entry
2015
Hold
11yr
Owners
2
Biomia
Nucleus Capital I
DenmarkSector
Biotech
InvestorNucleus Capital
Entry
2023
Hold
3yr
Owners
2
Bloom Science
Apollo Health Ventures Fund II
United StatesSector
Biotech
InvestorApollo Health Ventures
Entry
2021
Hold
5yr
Owners
2
Brenus Pharma
UI Investissement
FranceSector
Biotech
InvestorUI Investissement
Entry
2024
Hold
2yr
Owners
2
Carrick Therapeutics
Rosetta Capital V
UKSector
Biotech
InvestorRosetta Capital
Entry
2016
Hold
10yr
Owners
2
Cellvie
Oscar & Paul Venture Capital Fund I
SwitzerlandSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2021
Hold
5yr
Owners
2
Centessa Pharmaceuticals
General Atlantic
United StatesSector
Biotech
InvestorGeneral Atlantic
Entry
2021
Hold
5yr
Owners
2
Change Foods
Kale United
United StatesSector
Biotech
InvestorKale United
Entry
2022
Hold
4yr
Owners
2
Cytosolix
Backed Fund III
USASector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Owners
2
Dewpoint Therapeutics
Leaps by Bayer
USASector
Biotech
InvestorLeaps by Bayer
Entry
2019
Hold
7yr
Owners
2
DNA Script
Kurma Diagnostics II
FranceSector
Biotech
InvestorEurazeo
Entry
2017
Hold
9yr
Owners
2
eGenesis
Wellington Partners Life Sciences
United StatesSector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Owners
2
Elkedonia
Angelini Ventures
FranceSector
Biotech
InvestorAngelini Ventures
Entry
2025
Hold
1yr
Owners
2
Enodia Therapeutics
Elaia Legacy Fund
FranceSector
Biotech
InvestorLazard Elaia Capital
Entry
2026
Hold
0yr
Owners
2
Entact Bio
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2022
Hold
4yr
Owners
2
FundaMental Pharma
coparion
GermanySector
Biotech
Investorcoparion
Entry
2021
Hold
5yr
Owners
2
Glycomine
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2019
Hold
7yr
Owners
2
GreyWolf Therapeutics
Earlybird Health
United KingdomSector
Biotech
InvestorEarlybird Venture Capital
Entry
2018
Hold
8yr
Owners
2
Gyala Therapeutics
Nara Health Capital
SpainSector
Biotech
InvestorNara Capital Partners
Entry
2020
Hold
6yr
Owners
2
Hemarina
We Positive Invest
FranceSector
Biotech
InvestorArkea Capital
Entry
2014
Hold
12yr
Owners
2
Immunocore
Rosetta Capital V
United KingdomSector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Owners
2
InnoUp Farma
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2015
Hold
11yr
Owners
2
Inside Therapeutics
Newfund HEKA
FranceSector
Biotech
InvestorNewfund Management
Entry
2024
Hold
2yr
Owners
2
Istesso
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2017
Hold
9yr
Owners
2
Kynexis
Sunstone Life Science Ventures V
NL
Sector
Biotech
InvestorSunstone Life Science Ventures
Entry
2023
Hold
3yr
Owners
2
Leon Nanodrugs
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2015
Hold
11yr
Owners
2
Medibiofarma
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2019
Hold
7yr
Owners
2
MicroHarvest
Simon Capital Evergreen
GermanySector
Biotech
InvestorSimon Capital
Entry
2023
Hold
3yr
Owners
2
mo:re
Innovationsstarter Fonds Hamburg III
GermanySector
Biotech
InvestorIFB Innovationsstarter
Entry
2025
Hold
1yr
Owners
2
NanoSyrinx
BGF
UKSector
Biotech
InvestorBGF
Entry
2021
Hold
5yr
Owners
2